Leonard M. Greenstein is CFO at Tarsus Pharmaceuticals, Inc. (TARS). They have made 11 open-market trades across 2 companies since 2013, most recently 2026-01-28.
CIK 0001519692
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 11 sales. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| TARS | SELL · 10b5-1 | 2023-04-20 | 2023-04-21 | $14.02 | $70K | +2.6% | +10.3% | +57.8% |
| TARS | SELL | 2023-03-21 | 2023-03-23 | $12.55 | $13K | +3.7% | +21.4% | +52.5% |
| TARS | SELL | 2023-03-17 | 2023-03-21 | $12.94 | $8K | -2.3% | +12.6% | +48.2% |
| TARS | SELL | 2023-03-16 | 2023-03-17 | $13.44 | $71K | -0.9% | -2.4% | +44.7% |
| TARS | SELL | 2023-02-16 | 2023-02-17 | $15.12 | $76K | +1.7% | -14.7% | +5.4% |
| TARS | SELL | 2023-01-19 | 2023-01-20 | $14.56 | $73K | +5.0% | +1.3% | -2.8% |
| TARS | SELL | 2022-12-15 | 2022-12-16 | $14.64 | $73K | -2.3% | -2.7% | -10.2% |
| TARS | SELL | 2022-11-17 | 2022-11-18 | $16.54 | $83K | -0.9% | -17.2% | -11.3% |
| TARS | SELL | 2022-10-20 | 2022-10-28 | $15.91 | $157K | -3.6% | -9.5% | -13.6% |
| TARS | SELL | 2022-09-15 | 2022-09-16 | $16.03 | $80K | +19.2% | +16.7% | -1.1% |
| TARS | SELL | 2022-08-18 | 2022-08-19 | $16.30 | $82K | -4.5% | -3.3% | +2.2% |
| ELGX | SELL | 2013-05-28 | 2013-05-28 | $14.01 | $18K | -6.9% | +1.5% | +1.5% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.